Watermark
Go to Asia edition

‘Fantastic’ bonds kick Roche loan into touch

Roche’s plans for a jumbo loan have been thrown into doubt after the Swiss drugs group issued more than $14bn of bonds in Europe this week, adding to the $16bn trade it made last week in the US. The bonds mean Roche has little need to tap the bank market to fund its $42bn hostile bid for Genentech.

  • 26 Feb 2009

The borrower has said that as well as using cash to fund its $86.50 a share offer, it might also issue CP.

“I have absolutely no idea if there will be a loan anymore,” said a banker from an institution set to be one of the lead banks on ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Or sign up for a trial to gain full access to the entire site for a limited period.

Free Trial
Log in

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

GlobalCapital European securitization league table

Rank Lead Manager/Arranger Total Volume $m No. of Deals Share % by Volume
View full table
1 Citi 4,347 16 16.63
2 BNP Paribas 2,866 11 10.96
3 Morgan Stanley 2,420 6 9.26
4 Goldman Sachs 2,276 6 8.71
5 Bank of America Merrill Lynch (BAML) 2,086 9 7.98

Bookrunners of Global Structured Finance

Rank Lead Manager Amount $m No of issues Share %
View full table
For detailed analysis: Dealogic
  • Last updated
  • Today
1 Citi 58,403.50 191 10.83%
2 JPMorgan 50,900.93 151 9.44%
3 Bank of America Merrill Lynch 40,321.46 131 7.47%
4 Wells Fargo Securities 39,996.15 117 7.41%
5 Credit Suisse 37,748.55 119 7.00%